PLAAT4 (NM 004585) Humaan Recombinant Proteïne

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]

Purified recombinant protein of Human retinoic acid receptor responder (tazarotene induced) 3 (RARRES3), full length, with N-terminal His tag, expressed in E. coli, 50ug

HRASLS4; HRSL4; PLA1/2-3; PLAAT-4; RARRES3; RIG1; TIG3

5920

Q9UL19

NM_004585

11q12.3

E. coli

N-His

>50 ug/mL as determined by microplate BCA method

> 80% as determined by SDS-PAGE and Coomassie blue staining

Liquid

50mM Tris, 8M Urea, pH8.0.

Druggable Genome, Nuclear Hormone Receptor, Transmembrane

18 kDa

Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.

PLAAT4

Human

NP_004576

https://www.ncbi.nlm.nih.gov/gene/5920

https://www.uniprot.org/uniprot/Q9UL19

https://www.ncbi.nlm.nih.gov/nuccore/NM_004585

https://www.ncbi.nlm.nih.gov/nuccore/NP_004576